Lupus News and Research

Latest Lupus News and Research

MedImmune and Medarex have announced a collaboration to develop antibodies

MedImmune and Medarex have announced a collaboration to develop antibodies targeting interferon-alpha and the type I interferon receptor 1.

24 Nov 2004

New understanding of the role viruses play in the development of autoimmune diseases

Researchers at the La Jolla Institute for Allergy & Immunology have added a significant milestone to scientific understanding of the role viruses play in the development of autoimmune diseases, such as diabetes.

4 Nov 2004

Researchers identify biomarkers that could lead to more accurate diagnosis of systemic lupus erythematosus

University of Pittsburgh researchers have identified biomarkers that could result in earlier and more accurate diagnosis of systemic lupus erythematosus (SLE), a devastating disease that affects as many as 1.5 million Americans, and occurs 10 to 15 times more frequently in women.

4 Nov 2004

No convincing evidence that breast implants effect development of connective tissue disorders

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, found no convincing evidence that breast implants have an effect on the development of subsequent connective tissue disorders (CTDs).

19 Oct 2004

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

An investigational new drug for pulmonary hypertension may improve the quality of life for thousands of patients with scleroderma, lupus, and other associated connective tissue diseases, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Antonio, Texas.

18 Oct 2004

Mycophenolate mofetil is effective for managing symptoms of the most common type of lupus

Mayo Clinic investigators have found that the medication mycophenolate mofetil is effective for managing symptoms of systemic lupus erythematosus (SLE), the most common type of lupus, for patients whose SLE does not affect the kidneys.

18 Oct 2004

Biomedical engineers receive $11.5 million to study how white blood cells navigate

We all know the power of touch: A whack on the skull – or a hug – can convey more information than other forms of communication ever can. It turns out the same is true inside our bodies

12 Oct 2004

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in “Nature Immunology.”

11 Oct 2004

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

More than 150,000 children in the United States are affected by rheumatic diseases such as juvenile rheumatoid arthritis, lupus, dermatomyositis, scleroderma, and systemic vasculitis.

10 Oct 2004

Study on the long-term health effects associated with silicone breast implants

It is estimated that between 1.5 million and 2 million women in this country have had breast implants since they first appeared on the market in 1962.

23 Sep 2004

Important that nurses help women find ways to bond with their infants when breast-feeding is not possible

New mothers with fibromyalgia (FM) face multiple barriers to breast-feeding their babies, according to a study published recently in the American Journal of Maternal/Child Nursing.

20 Sep 2004

Cancer drug effective at treating lupus

A drug now used to treat a type of cancer appears to be very effective at treating lupus, with just one injection easing symptoms in several patients for a year or more.

16 Sep 2004

Cancer drug may reduce kidney disease in lupus

A drug that is already being tested as an anticancer agent, especially in lymphoma, may also reduce the kidney disease that is a result of systemic lupus, according to a researcher at Wake Forest University Baptist Medical Center.

10 Sep 2004

Novel disease mechanism underlying rheumatoid arthritis

Investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) have identified a novel disease mechanism underlying rheumatoid arthritis that may open the door to new therapies for this and other debilitating autoimmune disorders.

23 Aug 2004

Researchers find important gene for lupus

Researchers at the University of Minnesota have identified, for the first time, a gene variation associated with systemic lupus erythematosus (SLE), a potentially fatal disease which causes the body's defence system to attack itself.

18 Aug 2004

Genetic mutation is a major contributor to type 1 diabetes

A natural mutation of a gene that helps regulate the reactivity of the immune system is a major contributor to type 1 diabetes, Medical College of Georgia researchers have found.

12 Jul 2004

Relatively little is known about Lupus

Doctors have today launched an appeal for volunteers to take part in a new study into the widespread, yet largely unknown, autoimmune disease, SLE or Lupus.

1 Jul 2004

Mysterious disease that causes the body’s immune system to turn against itself

A mysterious disease that causes the body’s immune system to turn against itself also sends a warning signal to alert doctors of the onset of its worst symptoms, University of Florida physicians have found.

25 Jun 2004

Genetic variation that doubles the risk for rheumatoid arthritis

A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).

24 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Lupus News and Research

Latest Lupus News and Research

MedImmune and Medarex have announced a collaboration to develop antibodies

New understanding of the role viruses play in the development of autoimmune diseases

Researchers identify biomarkers that could lead to more accurate diagnosis of systemic lupus erythematosus

No convincing evidence that breast implants effect development of connective tissue disorders

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

Mycophenolate mofetil is effective for managing symptoms of the most common type of lupus

Biomedical engineers receive $11.5 million to study how white blood cells navigate

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

Study on the long-term health effects associated with silicone breast implants

Important that nurses help women find ways to bond with their infants when breast-feeding is not possible

Cancer drug effective at treating lupus

Cancer drug may reduce kidney disease in lupus

Novel disease mechanism underlying rheumatoid arthritis

Researchers find important gene for lupus

Genetic mutation is a major contributor to type 1 diabetes

Relatively little is known about Lupus

Mysterious disease that causes the body’s immune system to turn against itself

Genetic variation that doubles the risk for rheumatoid arthritis

Results from study of Rituxan in rheumatoid arthritis show promise

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lupus News and Research

Latest Lupus News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in